![Design, Synthesis and Biological Evaluation of Potent and Selective S1PR1 Agonists for the Treatment of Ulcerative Colitis - He - 2022 - Chinese Journal of Chemistry - Wiley Online Library Design, Synthesis and Biological Evaluation of Potent and Selective S1PR1 Agonists for the Treatment of Ulcerative Colitis - He - 2022 - Chinese Journal of Chemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9c41cc56-c461-401a-b80d-d5b363077ea0/cjoc202200392-fig-0001-m.jpg)
Design, Synthesis and Biological Evaluation of Potent and Selective S1PR1 Agonists for the Treatment of Ulcerative Colitis - He - 2022 - Chinese Journal of Chemistry - Wiley Online Library
![PPT - Discovery of the Novel, Orally Active S1P 1 Receptor Agonist ACT- 128800 (Ponesimod) PowerPoint Presentation - ID:3656570 PPT - Discovery of the Novel, Orally Active S1P 1 Receptor Agonist ACT- 128800 (Ponesimod) PowerPoint Presentation - ID:3656570](https://image2.slideserve.com/3656570/discovery-of-the-novel-orally-active-s1p-1-receptor-agonist-act-128800-ponesimod-l.jpg)
PPT - Discovery of the Novel, Orally Active S1P 1 Receptor Agonist ACT- 128800 (Ponesimod) PowerPoint Presentation - ID:3656570
![Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases. - Abstract - Europe PMC Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6689979/bin/fphar-10-00807-g005.jpg)
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases. - Abstract - Europe PMC
![Figure 1 from Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases. | Semantic Scholar Figure 1 from Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5e33908a37808dcb1aa18add1b3e4ff3107ad639/6-Figure1-1.png)